Nanopharm was established in 2002, we are the leading provider of tailored analytical and product development of orally inhaled and nasal drug products (OINDPs).

  Our unique processing technologies and formulation development tools enable seamless translation of pre-clinical development through to clinical manufacture of OINDPs. Nanopharm's integrated development services in materials characterisation, formulation development and inhaled biopharmaceutics aids successful product development of OINDPs by understanding how material properties and processing conditions influence product functionality. eqweqwe  


  • meet-a-team-img

    Prof. Rob Price

    Managing Director

    Prof. Robert Price is the founder of Nanopharm Ltd and has over 15 years experience in research and development of orally inhaled and nasal drug products. He is a Professor of Pharmaceutics at the University of Bath and holds a first-degree in Physics and a PhD in Surface Science. Rob has authored over 100 publications and has invented, developed and licensed novel technologies into the industry.

  • jag-shur

    Dr Jag Shur

    Managing Director

    Dr Jag Shur is a director of Nanopharm Ltd and has managed business operations and the successful growth of Nanopharm. He has over 15 years of experience in the development of orally inhaled and nasal drug products in both industry and academia, having held positions at Profile Therapeutics (Philips), GlaxoSmithKline and the University of Bath. Jag has a first degree in Chemistry, received his PhD in Inhaled Biopharmaceutics and has authored more than 30 scientific papers.